Literature DB >> 10671196

Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis.

P McGuirk1, K H Mills.   

Abstract

IL-12 plays a critical role in protective immunity against intracellular pathogens by promoting the development of Th1 cells. Here we demonstrate that filamentous hemagglutinin (FHA), a virulence factor of Bordetella pertussis, is capable of suppressing IL-12 production by macrophages. FHA inhibited IL-12 secretion by a macrophage cell line or ex vivo alveolar macrophages in response to Escherichia coli or B. pertussis lipopolysaccharide (LPS) and IFN-gamma. Antibodies to FHA or denaturation of FHA abrogated the inhibitory effect. Injection of mice with FHA suppressed IL-12 and IFN-gamma levels in the serum in response to i. v. injection of LPS in a model of septic shock. The suppressive effect of FHA was specific for IL-12, since the production of TNF-alpha, IL-6 and IL-10 was not suppressed, and production of IL-6 and IL-10 was up-regulated. Antibody blocking studies revealed that the inhibitory effect of FHA on IL-12 production was dependent on IL-10. Since FHA is secreted at high levels and local T cell responses are suppressed during B. pertussis infection, the findings suggest that FHA may be a critical virulence factor in facilitating pathogen persistence in the respiratory tract by suppressing or delaying the development of cell-mediated immunity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10671196     DOI: 10.1002/1521-4141(200002)30:2<415::AID-IMMU415>3.0.CO;2-X

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  53 in total

1.  Contribution of Bordetella filamentous hemagglutinin and adenylate cyclase toxin to suppression and evasion of interleukin-17-mediated inflammation.

Authors:  Michael W Henderson; Carol S Inatsuka; Amanda J Sheets; Corinne L Williams; David J Benaron; Gina M Donato; Mary C Gray; Erik L Hewlett; Peggy A Cotter
Journal:  Infect Immun       Date:  2012-04-02       Impact factor: 3.441

2.  Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice.

Authors:  U Sajjan; G Thanassoulis; V Cherapanov; A Lu; C Sjolin; B Steer; Y J Wu; O D Rotstein; G Kent; C McKerlie; J Forstner; G P Downey
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Osmolarity, a key environmental signal controlling expression of leptospiral proteins LigA and LigB and the extracellular release of LigA.

Authors:  James Matsunaga; Yolanda Sanchez; Xiaoyi Xu; David A Haake
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

4.  Acellular pertussis vaccines and complement killing of Bordetella pertussis.

Authors:  Alison A Weiss; Angela K Patton; Scott H Millen; Swei-Ju Chang; Joel I Ward; David I Bernstein
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

5.  Influence of CR3 (CD11b/CD18) expression on phagocytosis of Bordetella pertussis by human neutrophils.

Authors:  Paula S Mobberley-Schuman; Alison A Weiss
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

6.  Effects of a diphtheria-tetanus-acellular pertussis vaccine on immune responses in murine local lymph node and lung allergy models.

Authors:  Rob J Vandebriel; Eric R Gremmer; Michiel van Hartskamp; Jan A M A Dormans; Frits R Mooi
Journal:  Clin Vaccine Immunol       Date:  2007-01-03

7.  Intracellular trafficking of Bordetella pertussis in human macrophages.

Authors:  Yanina A Lamberti; Jimena Alvarez Hayes; Maria L Perez Vidakovics; Eric T Harvill; Maria Eugenia Rodriguez
Journal:  Infect Immun       Date:  2010-01-11       Impact factor: 3.441

8.  The prodomain of the Bordetella two-partner secretion pathway protein FhaB remains intracellular yet affects the conformation of the mature C-terminal domain.

Authors:  Christopher R Noël; Joseph Mazar; Jeffrey A Melvin; Jessica A Sexton; Peggy A Cotter
Journal:  Mol Microbiol       Date:  2012-10-05       Impact factor: 3.501

9.  Acellular pertussis vaccine protects against exacerbation of allergic asthma due to Bordetella pertussis in a murine model.

Authors:  Darren P Ennis; Joseph P Cassidy; Bernard P Mahon
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

10.  Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components.

Authors:  Ron Dagan; David Goldblatt; James R Maleckar; Mansour Yaïch; Juhani Eskola
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.